01
The Problem
Maternal risk often emerges quietly, between visits, in the intervals modern healthcare struggles to see. The result is preventable harm, uneven outcomes, and clinicians asked to make high-stakes decisions with incomplete information.
Venture
Agnes began in Nigeria as a maternal-health venture and was later reimagined for the United States as an AI-enabled Clinical Intelligence platform — exploring how longitudinal engagement, responsible AI, and clinician-centered decision support can surface emerging risk earlier.
Two Chapters
First Chapter · Nigeria
Founded before McKinsey to improve maternal-health information, engagement, and access to care. The early work reached approximately 5,000 women and revealed a deeper challenge: some of the most consequential changes in a patient's health happen outside the moments the healthcare system can see.
Reimagined · United States
After McKinsey, Agnes was reimagined — not continued — as an AI-enabled Clinical Intelligence platform. It explores how longitudinal patient engagement, clinical context, responsible AI, and human expertise can support earlier visibility into emerging maternal risk.
Illustration — placeholder
01
Maternal risk often emerges quietly, between visits, in the intervals modern healthcare struggles to see. The result is preventable harm, uneven outcomes, and clinicians asked to make high-stakes decisions with incomplete information.
02
Continuous, respectful engagement with patients across the care journey — combined with clinician-centered decision support — so risk is seen earlier and acted on together.
03
Intelligence is not automation. It is a system that helps clinicians see more clearly, decide with more confidence, and learn from every interaction.
04
Governance, transparency, and safety are designed into the platform from the first line of code — not retrofitted after deployment.
05
A world where every pregnancy is supported by intelligence that is continuous, humane, clinician-led, and demonstrably safe.
Continue
CoreLoop Advisory